{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-073501","form_type":"8-K","ticker":"BOLT","cik":"0001641281","company_name":"Bolt Biotherapeutics, Inc.","filed_at":"2024-06-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.382014+00:00","generated_at":"2026-06-01T04:20:22.920216+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Bolt Biotherapeutics annual meeting elects directors and ratifies auditor","bullets":["Director Kathleen LaPorte elected with 12,706,287 votes for, 3,990,176 withheld, 9,231,722 broker non-votes.","Director Nicole Onetto elected with 12,819,050 votes for, 3,880,294 withheld, 9,228,841 broker non-votes.","Ratification of PricewaterhouseCoopers LLP as auditor for FY2024: 23,736,566 for, 2,032,686 against, 158,933 abstaining.","Total shares represented at meeting: 25,928,185 of 38,127,740 shares entitled."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-073501","json":"https://secwatch.observer/filing/0000950170-24-073501.json","markdown":"https://secwatch.observer/filing/0000950170-24-073501.md","text":"https://secwatch.observer/filing/0000950170-24-073501.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/0000950170-24-073501-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1641281/000095017024073501/bolt-20240612.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T04:20:22.920216+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}